Daniel R. Chevallard, CFO at Regulus, holds 3.19K shares in LENZ Therapeutics (Ticker: LENZ), holds 102.31K shares in Viracta Therapeutics (Ticker: VIRX), holds 77.87K shares in Regulus (Ticker: RGLS). Most recently, Daniel R. Chevallard Bought ― shares of LENZ Therapeutics on May 15, 2024 for an estimated value of 49.99K.
What is the percentage of profitable transactions made by Daniel R. Chevallard?
The percentage of profitable transactions made by Daniel R. Chevallard is 50%.
What is the average return per transaction made by Daniel R. Chevallard?
The average return per transaction made by Daniel R. Chevallard is 16.00%.
What stocks does Daniel R. Chevallard hold?
Daniel R. Chevallard holds: RGLS, VIRX, LENZ stocks.
What was Daniel R. Chevallard’s latest transaction?
Daniel R. Chevallard latest transaction was an Informative Buy of $49.99K.
What was Daniel R. Chevallard's most profitable transaction?
Daniel R. Chevallard’s most profitable transaction was an Informative Buy of LENZ stock on May 15, 2024. The return on the trade was 105.90%.
What is Daniel R. Chevallard's role in Regulus?
Daniel R. Chevallard's role in Regulus is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.